NIA strongly believes that shares of Next Green Wave (OTCQX: NXGWF) will outperform all other cannabis stocks between now and year-end. NXGWF is NIA's third official #1 California cannabis stock suggestion, with NIA's two previous California cannabis stock suggestions gaining an average of 143.35% at their highs from NIA's official suggestion prices!
From NIA's official suggestion price this morning of $0.276 per share a gain of 143.35% would send its shares up to $0.672 per share. Already, back on January 15th, NXGWF gained 40% in a single day to reach a record high of $0.675 per share after announcing a major strategic licensing agreement to utilize Intrexon (XON)'s Botticelli™ next generation plant propagation platform to enable rapid production of NXGWF's proprietary cannabis cultivars for the California market.
Barbra Streisand made global headlines last year after announcing that she cloned her dog. Click here to read the March 2, 2018 article written by Barbra Streisand and published in the New York Times entitled, 'Barbra Streisand Explains: Why I Cloned My Dog'. In this article, Streisand said, "So Sammie’s doctor took some cells from inside her cheek and the skin on her tummy just before she died. And we sent those cells to ViaGen Pets in Texas. We weren’t even sure if the cells would take." ViaGen Pets is currently the only U.S. company with the ability to clone dogs and the only company in the world with the ability to clone cats. ViaGen Pets is owned by ViaGen Inc., which is a subsidiary of Trans Ova Genetics; and Trans Ova Genetics is owned by the publicly traded NASDAQ company Intrexon (XON).
XON is the world leader in the field of synthetic biology, focusing on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals.designs and engineers living systems to address the world's greatest challenges in health, energy, good, and environmental sustainability. XON owns the best possible domain name for its corporate web site www.dna.com
In recent years, XON has invested major resources on researching advances in the production of cannabis. XON's largest single day gain in history occurred back on September 24, 2018, when the company announced that it had engineered a yeast strain to produce low-cost, robust and consistent cannabinoid outputs via fermentation. XON said that by utilizing microbes it was aiming to provide greater supply-chain security, while avoiding the resource-intensive isolation that often leads to quality and quantity variability in end products.
XON on September 24th following this announcement gapped up from its previous close of $14.50 to open at $15.99 and rallied as high as $19.94 per share for a single day gain of 37.5% at its high on massive volume of 19.529 MILLION shares! XON's market cap increased by $746 MILLION in a single day to a peak of $2.735 BILLION! After closing January 14, 2019 at $7.86 per share, XON announced its agreement with NXGWF the following day and immediately exploded for four days straight by $1.24 or 15.78% to a 2019 high of $9.10 per share!
Considering the major advantages that XON's Botticelli™ next generation plant propagation platform achieves over the labor intensive, costly, and non-sustainable methods of cannabis cultivation used today, XON could have signed a deal for the California cannabis market with literally any cultivator of its choice. By XON selecting NXGWF to advance its technology in the California market, which is the world's largest cannabis market - representing 1/3 of total U.S. cannabis revenue, NXGWF has been validated by XON as the most innovative and technologically advanced vertically integrated cannabis company in all of California!
For the Florida market, XON has signed an identical strategic licensing agreement with Surterra Wellness. Currently, Surterra Wellness operates 23 dispensaries in Florida, behind only Curaleaf (CURLF) with 24 and Trulieve (TCNNF) with 28. Although Surterra is a private company, CURLF has a market cap of $3.625 BILLION and TCNNF has a market cap of $1.19 BILLION! Surterra has undoubtedly reached unicorn status with a private valuation north of $1 BILLION! On August 6, 2018, Surterra raised $65 MILLION in series C funding, increasing its total capital raised since 2015 up to $100 million. The lead investor in the $65 million round was billionaire Wrigley chewing gum heir William “Beau” Wrigley Jr! On November 14, 2018, Wrigley was appointed the new Chairman and CEO of Surterra!
Over the last two days, XON has soared by $0.87 or 15.68% to $6.42 per share! XON's market cap is now back above $1 BILLION! Considering that XON selected a BILLION dollar unicorn Surterra Wellness to license its breakthrough Botticelli™ cannabis cultivation technology to for the state of Florida, and Surterra is led by Beau Wrigley who has a net worth of $2.9 BILLION - NXGWF at its current insanely low market cap will undoubtedly become the best performing cannabis stock of the second half of 2019 in NIA's opinion! XON has selected NXGWF to use its Botticelli™ cannabis cultivation technology in the much larger and more important California market! We believe NXGWF definitely deserves a market cap of well over $100 million!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from NXGWF of USD$60,000 cash for a two-month marketing contract. Never make investment decisions based on anything NIA says. This message is meant for informational and educational purposes only and does not provide investment advice.